查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553526

数位治疗市场规模、份额、趋势分析报告：按应用、按最终用途、按地区、细分市场预测，2024-2030 年

Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity), By End Use (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

数位治疗市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球数位治疗市场规模将达325.2亿美元，2024年至2030年复合年增长率为27.2%。

扩大市场成长的主要因素是智慧型手机的普及。医疗保健提供者和患者对数位医疗技术的负担能力、对综合医疗保健系统不断增长的需求以及以患者为中心的护理是推动市场成长的关键因素。此外，全球化的进步和生活方式的改变，例如烟草使用增加、营养缺乏、缺乏运动和消费量增加，正在增加慢性病的可能性。

数位疗法的日益普及以及 FDA 等主要监管机构的支持措施对市场扩张产生了重大影响。例如，2020 年 4 月，美国FDA 发布了指导方针，加强对精神疾病患者使用数位治疗设备的指导。此外，根据Kepios资料，全球网路用户年增率为7.6%，相当于每天新增约90万网路用户。已开发国家和开发中开发中国家的智慧型手机和网路使用率都很高，但非洲和南亚等地区面临经济限制，需要迎头赶上。

慢性病盛行率的增加也推动了市场的成长。根据疾病预防控制中心国家慢性病预防与健康促进中心的数据，十分之六的美国成年人患有慢性病，十分之四的成年人患有两种或两种以上慢性病。例如，2022 年 2 月，Teladoc Health, Inc. 推出了 Chronic Care Complete，这是一种旨在改善医疗保健结果的慢性病管理解决方案。心血管疾病、癌症、糖尿病、慢性肾臟病、慢性肺病和阿兹海默症已被确定为该国死亡和残疾的主要原因。

数位疗法已成为治疗各种健康状况的重要选择，这主要归功于行业主要企业的客製化治疗计划和策略性倡议。这些行动包括併购、获得监管部门的核准、推出新产品以及建立合作关係。此外，心血管疾病、糖尿病和焦虑症等慢性病的盛行率不断上升，正促使市场主要参与者投资数位治疗解决方案。多家公司正在开发专门用于焦虑管理的数位治疗产品，其中许多产品正处于不同的研发阶段。这代表着巨大的市场成长机会。例如，2023 年 8 月，WellDoc 宣布其 BlueStar（一种用于糖尿病管理的数位健康解决方案）获得了第 10 次 FDA 510(k) 批准。此次批准使 BlueStar 能够将关联的胰岛素剂量资讯纳入Bolus胰岛素给药的客製化建议中。

数位治疗市场报告亮点

  • 从应用来看，由于该行业市场参与企业技术的快速进步，糖尿病在 2023 年占据了 29.36% 的市场占有率。预计该细分市场在预测期内也将出现最快的成长。
  • 由于患有慢性病的患者数量不断增加，2023年患者细分市场占据最大市场占有率，达到34.08%。数位疗法还可以帮助改善治疗的可及性，特别是对于农村和偏远地区的人们。
  • 由于对数位疗法的高需求，北美将在 2023 年主导全球市场。由于医疗保健意识的提高和数位健康产品的使用增加，预计这些区域市场在预测期内将表现出类似的趋势。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章数字治疗市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 数位治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章数位治疗市场：按应用进行估计和趋势分析

  • 2023 年和 2030 年按应用分類的市场占有率
  • 细分仪表板
  • 全球数位治疗市场应用前景展望
  • 糖尿病
    • 2018-2030 年市场估计与预测
  • 肥胖
    • 2018-2030 年市场估计与预测
  • 心血管疾病（CVD）
    • 2018-2030 年市场估计与预测
  • 呼吸系统疾病
    • 2018-2030 年市场估计与预测
  • 禁止抽烟
    • 2018-2030 年市场估计与预测
  • 中枢神经系统 (CNS) 疾病
    • 2018-2030 年市场估计与预测
  • 其他的
    • 2018-2030 年市场估计与预测

第五章 数位治疗市场：最终用途的估计和趋势分析

  • 2023 年和 2030 年按最终用途分類的市场占有率
  • 细分仪表板
  • 按最终用途分類的全球数位治疗市场展望
  • 病人
  • 提供者
  • 付款人
  • 雇主
  • 其他的

第六章 数位治疗市场：按应用和最终用途分類的区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 公司简介
    • OMADA HEALTH, INC.
    • Welldoc, Inc.
    • 2Morrow, Inc
    • Livongo Health, Inc.（Teladoc Health, Inc.）
    • Propeller Health（ResMed）
    • Fitbit LLC
    • Mango Health
    • CANARY HEALTH
    • Noom, Inc.
    • Pear Therapeutics, Inc.
    • Akili Interactive Labs, Inc.
    • HYGIEIA
    • DarioHealth Corp.
    • BigHealth
    • GAIA AG
    • Limbix Health, Inc.
Product Code: GVR-1-68038-768-1

Digital Therapeutics Market Growth & Trends:

The global digital therapeutics market size is expected to reach USD 32.52 billion by 2030, exhibiting a CAGR of 27.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary driver for expanding the market growth is the increased use of smartphones. The affordability of digital health technologies for healthcare providers & patients, rising demand for integrated healthcare systems, and care focusing on the patient are key factors fueling the market's growth. Furthermore, the growing globalization and shifts in lifestyle habits, such as higher rates of tobacco use, inadequate nutrition, insufficient physical activity, and rising alcohol consumption, increase the likelihood of chronic disease development.

The market's expansion is significantly influenced by the increasing adoption of digital therapeutics and the supportive initiatives by leading regulatory agencies such as the FDA. For instance, the U.S. FDA provided guidelines in April 2020 to enhance the reach of digital therapeutic devices for people suffering from psychiatric disorders. Furthermore, according to Kepios data, there's a 7.6% annual growth rate in the global internet user base, translating to around 900,000 new internet users daily. While developed and developing nations boast high smartphone and internet usage levels, areas such as Africa and South Asia need to catch up due to their economic limitations.

Increasing prevalence of chronic diseases is also driving the growth of the market. As per the CDC's National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 American adults suffer from a chronic disease, while 4 out of 10 adults have two or more chronic diseases. For instance, in February 2022, Teladoc Health, Inc. launched Chronic Care Complete, a chronic condition management solution to improve healthcare outcomes. Cardiovascular diseases, cancer, diabetes, chronic kidney disease, chronic lung disease, and Alzheimer's have been identified as the leading causes of death and disability in the country.

Digital therapeutics have become an essential option for treating various health conditions, mainly due to customized treatment plans and strategic initiatives by leading companies in the industry. These actions include mergers and acquisitions, clearing regulatory approvals, introducing new products, and establishing partnerships. Moreover, the growing rates of chronic diseases such as cardiovascular disease, diabetes, and anxiety have driven critical players in the market to invest in digital solutions for treatment. Various companies are in the process of developing digital therapeutic products aimed specifically at managing anxiety, with many of these products in different phases of research and development. This presents a significant opportunity for market growth. For instance, In August 2023, Welldoc revealed it had obtained its 10th FDA 510(k) clearance for the BlueStar digital health solution for diabetes management. This clearance allows BlueStar to incorporate connected insulin dosing information into its customized recommendations for bolus insulin dosing.

Digital Therapeutics Market Report Highlights:

  • Based on application, diabetes held a market share of 29.36% in 2023, owing to rapid technological advancements by market players in the segment. The segment is also expected to witness the fastest growth over the forecast period
  • The patients segment held the largest market share of 34.08% in 2023, owing to the growing number of patients suffering from chronic conditions. Digital therapeutics can also help improve access to care for people, especially those from rural and remote areas
  • North America dominated the global market in 2023 owing to the high demand for digital therapeutics in the region. These regional marketplaces are expected to show similar trends throughout the forecast period due to rising healthcare awareness coupled with increased use of digital health products over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Digital Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Digital Therapeutics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Digital Therapeutics Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Digital Therapeutics Market by Application Outlook
  • 4.4. Diabetes
    • 4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.5. Obesity
    • 4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.6. Cardiovascular Disease (CVD)
    • 4.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.7. Respiratory Diseases
    • 4.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.8. Smoking Cessation
    • 4.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.9. Central Nervous System (CNS) Disease
    • 4.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Digital Therapeutics Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Digital Therapeutics Market by End Use Outlook
  • 5.4. Patients
    • 5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.5. Providers
    • 5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.6. Payers
    • 5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.7. Employers
    • 5.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. Digital Therapeutics Market: Regional Estimates & Trend Analysis, By Application, By End Use

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.6. Denmark
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.8. Norway
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Company Profiles
    • 7.3.1. OMADA HEALTH, INC.
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Welldoc, Inc.
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. 2Morrow, Inc
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Livongo Health, Inc. (Teladoc Health, Inc.)
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Propeller Health (ResMed)
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Fitbit LLC
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Mango Health
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. CANARY HEALTH
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Noom, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Pear Therapeutics, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Akili Interactive Labs, Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. HYGIEIA
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. DarioHealth Corp.
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. BigHealth
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. GAIA AG
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. Limbix Health, Inc.
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 4 North America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 5 North America digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. macro dynamics
  • Table 7 U.S. digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada macro dynamics
  • Table 10 Canada digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico macro dynamics
  • Table 13 Mexico digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 18 UK macro dynamics
  • Table 19 UK digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 20 UK digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 21 Germany macro dynamics
  • Table 22 Germany digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 24 France macro dynamics
  • Table 25 France digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 26 France digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 27 Italy macro dynamics
  • Table 28 Italy digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 29 Italy digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 30 Spain macro dynamics
  • Table 31 Spain digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 32 Spain digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 33 Denmark macro dynamics
  • Table 34 Denmark digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 35 Denmark digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 36 Sweden macro dynamics
  • Table 37 Sweden digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 38 Sweden digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway macro dynamics
  • Table 40 Norway digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 41 Norway digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific digital therapeutics market estimates and forecasts, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 46 Japan macro dynamics
  • Table 47 Japan digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 48 Japan digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 49 China macro dynamics
  • Table 50 China digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 51 China digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 52 India macro dynamics
  • Table 53 India digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 54 India digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 55 Australia Macro dynamics
  • Table 56 Australia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 57 Australia digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 58 Thailand macro dynamics
  • Table 59 Thailand digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 60 Thailand digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 61 South Korea macro dynamics
  • Table 62 South Korea digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 63 South Korea digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 64 Latin America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 65 Latin America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 66 Latin America digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 67 Brazil macro dynamics
  • Table 68 Brazil digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 69 Brazil digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 70 Argentina macro dynamics
  • Table 71 Argentina digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 72 Argentina digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 73 MEA digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 74 MEA digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 75 MEA digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 76 South Africa macro dynamics
  • Table 77 South Africa digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 78 South Africa digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia Macro dynamics
  • Table 80 Saudi Arabia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 82 UAE Macro dynamics
  • Table 83 UAE digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 84 UAE digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 85 Kuwait Macro dynamics
  • Table 86 Kuwait digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 87 Kuwait digital therapeutics market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 88 Key company heat map analysis/company position analysis

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Estimation methodology
  • Fig. 4 Data triangulation techniques
  • Fig. 5 Primary research pattern
  • Fig. 6 Market research approaches
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD modeling for market share assessment
  • Fig. 9 Market formulation & validation
  • Fig. 10 Commodity flow analysis
  • Fig. 11 Digital therapeutics market snapshot, 2023 (USD Million)
  • Fig. 12 Segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook
  • Fig. 15 Ancillary market outlook
  • Fig. 16 Digital Therapeutics market dynamics
  • Fig. 17 Digital therapeutics market driver impact
  • Fig. 18 Annual cost per person (USD) for key chronic conditions & by no. of co-morbidities
  • Fig. 19 Top countries by smartphone users, 2021
  • Fig. 20 Digital therapeutics market restraint impact
  • Fig. 21 Market participation categorization
  • Fig. 22 Market leaders and innovators
  • Fig. 23 Company market position analysis
  • Fig. 24 Major deals & strategic alliances analysis
  • Fig. 25 Digital therapeutics market: Application movement analysis
  • Fig. 26 Digital therapeutics Market: Application dashboard
  • Fig. 27 Global diabetes market, 2018 - 2030 (USD Million)
  • Fig. 28 Global obesity market, 2018 - 2030 (USD Million)
  • Fig. 29 Global CVD market, 2018 - 2030 (USD Million)
  • Fig. 30 Global respiratory diseases market, 2018 - 2030 (USD Million)
  • Fig. 31 Global smoking cessation market, 2018 - 2030 (USD Million)
  • Fig. 32 Global CNS diseases market, 2018 - 2030 (USD Million)
  • Fig. 33 Global others market, 2018 - 2030 (USD Million)
  • Fig. 34 Digital therapeutics market: End use movement analysis
  • Fig. 35 Digital therapeutics market: End use dashboard
  • Fig. 36 Global patients market, 2018 - 2030 (USD Million)
  • Fig. 37 Global providers market, 2018 - 2030 (USD Million)
  • Fig. 38 Global payers market, 2018 - 2030 (USD Million)
  • Fig. 39 Global employers market, 2018 - 2030 (USD Million)
  • Fig. 40 Global other end uses market, 2018 - 2030 (USD Million)
  • Fig. 41 Regional marketplace: Key takeaways
  • Fig. 42 North America: SWOT analysis
  • Fig. 43 North America digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe: SWOT analysis
  • Fig. 48 Europe digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 49 UK digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 51 France digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 52 Italy digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 55 Norway digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific: SWOT analysis
  • Fig. 58 Asia Pacific Digital Therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 60 China digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 61 India digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 64 Thailand digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 65 Latin America: SWOT analysis
  • Fig. 66 Latin America digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 67 Mexico digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 70 Middle East and Africa: SWOT analysis
  • Fig. 71 Middle East and Africa digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia digital therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 74 UAE digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Kuwait digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Heat map analysis
  • Fig. 77 List of key emerging companies/technology disruptors/innovators